Examples of using In vitro data in English and their translations into Slovak
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Based upon in vitro data, chronic administration of vorapaxar is unlikely to induce the metabolism of drugs metabolized by major CYP isoforms.
In vitro data and studies in laboratory animals indicate that 99mTc-depreotide binds with high affinity to somatostatin receptor(SSTR)
In vitro data indicate that enzalutamide
In vitro data indicate that enzalutamide is not a substrate for OATP1B1,
In vitro data indicate that ledipasvir may be a weak inducer of metabolising enzymes such as CYP3A4,
In vitro data show that CYP2C9,
In vitro data show that CYP2C9,
In vitro data suggests that the majority of NS5A RAVs that confer resistance to ledipasvir
In vitro data in human plasma indicate that doxazosin has no effect on protein binding of digoxin,
For example, in vivo and in vitro data carry more weight in the decision than a QSAR
In vitro data in human plasma indicate that doxazosin has no effect on protein binding of digoxin,
The Applicant concluded that the in vitro data and the negligible clinical relevance of the differences detected were supported by the provided in vivo study.
In vitro data indicate that the MMAE metabolism that occurs is primarily via oxidation by CYP3A4/5.
In vitro data indicate that this is predominantly mediated by CYP3A4, and to a small extent by CYP1A2 and CYP2A6.
In vitro data indicate that this is predominantly mediated by the cytochrome P450 3A4 isoform(CYP3A4).
In vitro data indicate that ulipristal acetate
In vitro data indicate that ulipristal acetate may be an inhibitor of BCRP(Breast Cancer Resistance Protein)
In vitro data indicate that ulipristal acetate may be an inhibitor of P-gp at clinically relevant concentrations in the gastrointestinal wall during absorption.
In vitro data indicate that ulipristal acetate may be an inhibitor of P-gp at clinically relevant concentrations.
In vitro data suggest that bazedoxifene is unlikely to interact with co-administered medicinal products via CYP-mediated metabolism.